All Trending News
News by Trendlyne
My Newsfeed
My Stocks
Sectors/Interests
People
New Stock Reports
Highest Upside
Buy
Sell
Upgrades
Downgrades
IPO
Latest Triggered Alerts
My Alerts
Configure Alerts
My Screeners
Expert Screeners
Fundamentals
Share Holding
Technical
Candlestick
Price/Volume
Moving Avg.
Following
Followers
Stocks
Sector/Interests
Portfolio
Power Analysis
NEW
Watch List
Transactions
Import Portfolio
Tax Saving
Large cap
Small & Midcap
Diversified Equity
Equity Sectoral
Debt
Hybrid
Liquid and Gilt
Trendlyne
PREMIUM
Newsfeed
All Trending News
News by Trendlyne
My Newsfeed
My Stocks
Sectors/Interests
People
Reports
New Stock Reports
Highest Upside
Buy
Sell
Neutral
IPO
Thematic
Screeners
My Screeners
Expert Screeners
Fundamentals
Share Holding
Technical
Candlestick
Price/Volume
Moving Avg.
Mutual Funds
Tax Saving
Large cap
Small & Midcap
Diversified Equity
Equity Sectoral
Debt
Hybrid
Liquid and Gilt
SUPERSTARS
Shareholder Portfolios
Bulk Block Deals
PORTFOLIO
Portfolio
Superstar Shareholders
Watch List
RESULTS
ALERTS
Latest Triggered Alerts
My Alerts
Configure Alerts
Connections
Following
Followers
Stocks
Sector/Interests
What's New
Shareholder Portfolios
Bulk Block Deals
Newsfeed
Reports
Screeners
Premium
SUPERSTARS
PORTFOLIO
Results
More
Premium
MUTUAL FUNDS
PORTFOLIO
ALERTS
Connections
What's New
Stocks
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Share Holding
Search stocks
Stocks
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Share Holding
Alembic Pharmaceuticals Ltd.
NSE: APLLTD
|
BSE: 533573
|
ISIN: INE901L01018
|
Industry: Pharmaceuticals
|
Expensive Performer
568.00
2.75
(
0.49
%)
NSE
Nov 21, 2018
15:31
37.07% Gain from 52W Low
Volume:
12,849
Share on Facebook
Tweet
Share on Google+
Share on LinkedIn
Share via Whatsapp
Overview
Diary
Fundamentals
NEWS
Reports
Technicals
Alerts
SHARE HOLDING
Corporate Actions
Dividend
Bonus
Split
Deals
Durability score
60
/100
Valuation score
25.3
/100
Momentum score
49.1
/100
Market Capitalizati...
10,706.8
Cr.
AVG Broker Target
583
PE TTM Price to Ear...
20.4
Analyst Rating
3
/5
No of reports
17
Recommendation upgrades
1
Recommendation downgrade
1
Featured In Screens
12
Price to Book Value
4.82
Revenue Qtr Cr
c
1,127.06
Cr
Net Profit Qtr Cr
c
199.97
Cr
RSI
40.22
MFI
31.81
MACD
-7.57
MACD signal
-5.72
SMA 30
585.08
SMA 50
602.99
SMA 100
581.44
SMA 200
548.10
Promoter holding %
72.96
FII holding %
9.32
MF holding %
5.14
Institutional holding %
14.88
Previous
Next
Price
Price
PE
PB
Div. Yield
EPS
SCORE
Auto
Real
Zero Base
1D
1W
1M
3M
6M
1Y
2Y
5Y
max
Technicals
|
Save image
Technicals
Indicators
Exponential Moving Average
Simple Moving Average
Bollinger Bands
Period
Indicators
Exponential Moving Average
Simple Moving Average
Bollinger Bands
Period
Indicators
Exponential Moving Average
Simple Moving Average
Bollinger Bands
Period
Save as image
STOCKNAME
Auto
Real Value
Zero Base
Send to
Left axis
Right axis
Go to..
×
Close
Save chart as image
Fetching latest news from server
Poll
VOTE: What's your call on Alembic Pharmaceuticals Limited?
BUY
SELL
HOLD
BUY
SELL
83.33%
16.67%
RESEARCH REPORTS
Neutral:
Alembic Pharmaceutic..
by
HDFC Securities
Target: 610 |
Target met
23 Oct 2018
Hold:
Alembic Pharmaceutic..
by
ICICI Securities Limited
Target: 560 |
Target met
23 Oct 2018
All reports of APLLTD
ALERTS
Stock Price (565.70) crossed below
100 Day SMA
(580.06) on 16 November, 2018
ICICI Securities Limited increased Hold price target of Alembic Pharmaceuticals Ltd. to 560.0 on 23 Oct, 2018.
Day volume (498807) was 479% of the
Month Average Volume
(104058.0) on 22 October, 2018
Stock Price (592.10) crossed below
30 Day SMA
(621.35) on 04 October, 2018
Stock Price (592.10) crossed below
50 Day SMA
(601.63) on 04 October, 2018
More triggered alerts
CORPORATE ANNOUNCEMENTS
Alembic Pharmaceutic..
|
20 Nov 2018, 10:48AM
Announcement under Regulation 30 (LODR)-Press Release / Media Release - With reference to the ...
Alembic Pharmaceutic..
|
30 Oct 2018
Announcement under Regulation 30 (LODR)-Credit Rating - Pursuant to the provisions of Regulation 30 ...
Alembic Pharmaceutic..
|
26 Oct 2018
Completion Of US FDA Inspection Of General Oral Solid Formulation Facility - We would ...
Alembic Pharmaceutic..
|
24 Oct 2018
Announcement under Regulation 30 (LODR)-Newspaper Publication - Pursuant to Regulation 30 of the SEBI ...
Alembic Pharmaceutic..
|
22 Oct 2018
Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2018. ...
See All BSE Corporate Announcements of APLLTD
CORPORATE ACTIONS
Dividends
Ex-Date Dividend
Amount
Dividend Type
Record Date
July 18, 2018
4.00
FINAL
-
July 11, 2017
4.00
FINAL
-
July 20, 2016
4.00
FINAL
-
July 22, 2015
3.50
FINAL
-
July 17, 2014
3.00
FINAL
-
All dividends by APLLTD
Popular on Trendlyne
Volume Shockers: Dr. Reddy's Labs gains, Jindal Stainless ...
Stock Screener: Companies that announced results in past ...
Central Bank versus Centre: All eyes on RBI ...
Performance review: Larsen & Toubro (L&T) sees growth ...
more
Loading Financials
Popular on Trendlyne
Volume Shockers: Dr. Reddy's Labs gains, Jindal Stainless ...
Stock Screener: Companies that announced results in past ...
Central Bank versus Centre: All eyes on RBI ...
Performance review: Larsen & Toubro (L&T) sees growth ...
